Investigates switching to subcutaneous methotrexate for alleviating intolerance symptoms in Japanese rheumatoid arthritis patients, suggesting potential benefits.
Objectives To investigate the efficacy of switching from oral to subcutaneous methotrexate (MTX) in alleviating MTX-related intolerance symptoms in Japanese patients with rheumatoid arthritis (RA).
No takes yet. Share an insight, caveat, or question.
Ohmura et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: